SelectQuote (SLQT) closed the last trading session at $5.49, gaining 23.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.33 indicates a 33.5% upside potential.The average comprises three short-term price targets ranging from a low of $7 to a high of $8, with a standard deviation of $0.58. While the lowest estimate indicates an increase of 27.5% from the current price level, th ...

SelectQuote, Inc. (NYSE:SLQT) Q2 2025 Results Conference Call February 10, 2025 5:00 PM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants Benjamin Hendrix - RBC Capital Markets George Sutton - Craig Hallum Pat McCann - NOBLE Capital Markets Operator Good afternoon, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator t ...

SelectQuote (SLQT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 233.33%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of $0.26, delivering a surprise of -44.44%.Over the last four quarters, the company has su ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...

Exhibit 10.5 TWELFTH AMENDMENT TO CREDIT AGREEMENT THIS TWELFTH AMENDMENT TO CREDIT AGREEMENT (this "Agreement") is entered into as of February 10, 2025, by and among SELECTQUOTE, INC., a Delaware corporation, as the Borrower, the other Credit Parties party hereto, the Twelfth Amendment Consenting Lenders (as defined below), ARES CAPITAL CORPORATION, as the administrative agent (in such capacity, the "Administrative Agent"), and UMB BANK, N.A., as the revolver agent (in such capacity, the "Revolver Agent"). ...

SelectQuote, Inc. (NYSE:SLQT) Q1 2025 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Bill Grant - Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets George Sutton - Craig-Hallum Pat McCann - NOBLE Capital Markets Operator Welcome to SelectQuote's First Quarter Earnings [Technical Difficulty]. All lines have been plac ...

Policy Submissions and Approvals - Total submitted policies decreased by 1% to 118,537 for the three months ended September 30, 2024, compared to 119,452 in the same period of 2023[90] - Total approved policies decreased by 5% to 104,659 for the three months ended September 30, 2024, compared to 109,876 in the same period of 2023[92] - Medicare Advantage plans accounted for 88% of approved Senior policies for the three months ended September 30, 2024[83] Financial Performance - Total revenue for the three months ended September 30, 2024, was $292,263,000, representing a 26% increase from $232,730,000 in the same period of 2023[102] - Revenue from the Senior segment was $92.9 million for the three months ended September 30, 2024, a $3.0 million, or 3%, increase compared to $89.9 million for the same period in 2023[124] - Revenue from Healthcare Services was $155.7 million for the three months ended September 30, 2024, a $58.4 million, or 60%, increase compared to $97.4 million for the same period in 2023[125] - Revenue from the Life segment was $39.3 million for the three months ended September 30, 2024, a $1.5 million, or 4%, increase compared to $37.8 million for the same period in 2023[126] - The company completed a $100.0 million securitization transaction on October 15, 2024, to provide advanced financing against expected collections for previously sold policies[131] - The company expects to remain in compliance with debt covenants for the next 12 months based on financial projections[130] Expenses and Losses - Selling, general, and administrative expenses increased by $7.5 million, or 26%, primarily due to a $5.2 million increase in compensation costs[110] - Marketing and advertising expenses rose by $1.4 million, or 2%, mainly due to a $0.8 million increase in lead costs[108] - Net loss for the three months ended September 30, 2024, was $44,546,000, compared to a net loss of $31,051,000 in the same period of 2023[99] - Interest expense increased by $1.6 million, or 8%, due to higher interest rates during the period[112] - Technical development expenses increased by $1.4 million, or 19%, primarily due to a $1.6 million increase in compensation costs for technology personnel[112] - The net loss for the three months ended September 30, 2024, was $44.5 million, with non-cash adjustments totaling $26.3 million[138] Membership and Operations - Total number of SelectRx members increased by 64% to 86,521 as of September 30, 2024, compared to 52,750 in the same period of 2023[96] - Average prescriptions shipped per day increased to 24,998 for the three months ended September 30, 2024, compared to 15,479 in the same period of 2023[97] - The increase in Healthcare Services revenue was primarily due to a $58.1 million increase in SelectRx pharmacy revenue[125] Cash Flow and Debt - Cash and cash equivalents decreased to $10.4 million as of September 30, 2024, from $42.7 million as of June 30, 2024[134] - Net cash used in operating activities for the three months ended September 30, 2024, was $16.6 million, compared to $23.7 million for the same period in 2023[138][140] - Net cash used in investing activities was $2.6 million for the three months ended September 30, 2024, primarily due to $2.1 million in software purchases[142] - Net cash used in financing activities was $13.1 million for the three months ended September 30, 2024, mainly due to $8.5 million in principal payments on term loans[144] - As of September 30, 2024, total debt obligations amounted to $680.4 million, slightly down from $683.3 million as of June 30, 2024[132] Market and Competitive Position - The company continues to seek opportunities for market expansion through acquisitions and partnerships in healthcare services[82] - The proprietary routing and workflow system is a key competitive advantage that enhances sales and customer retention[81] - The company remains exposed to market risks associated with unfavorable movements in interest rates, with no material changes to its risk policies[147]

| --- | --- | --- | --- | --- | --- | |-------|--------------------------------------------------------|-------|-------|-------|-------| | 1 st | Quarter Fiscal 2025 | | | | | | | Earnings Conference Call Presentation November 4, 2024 | | | | | | | | | | | | | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance ...

Exhibit 99.1 SelectQuote, Inc. Reports First Quarter of Fiscal Year 2025 Results First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights • Revenue of $292.3 million • Net loss of $44.5 million • Adjusted EBITDA* of $(1.7) million Fiscal Year 2025 Guidance Ranges: • Revenue expected in a range of $1.425 billion to $1.525 billion • Net income (loss) expected in a range of $(59) million to $3 million • Adjusted EBITDA* expected in a range of $100 million to $130 million First Quarter Fiscal Year 2 ...

It might be surprising for some to hear that 2024 has been a great year for stocks in the insurance industry. In fact, every single large-cap insurance stock in the United States and Canada trading region has a positive return this year. Additionally, the iShares U.S. Insurance ETF NYSEARCA: IAK has provided a total return of nearly 29%. Some stocks, like Progressive NYSE: PGR, are up more than 50%. SelectQuote NYSE: SLQT is no exception to the success of this industry. Shares are up 54% this year. However, ...